Market Overview:
The global Chlorthalidone API market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing use of Chlorthalidone API in research and pharmaceutical applications. Additionally, the growing demand for generic drugs is also contributing to the growth of this market. However, stringent regulatory norms and high manufacturing costs are restraining the growth of this market. On the basis of type, Chlorthalidone API with purity above 97% accounted for a major share of the global market in 2017. This segment is expected to grow at a CAGR of 5.8% during the forecast period from 2018 to 2030 due to its high purity and superior quality as compared to other types available in the market. On the other hand, Chlorthalidone API with purity less than or equal 97% accounted for a minor share of this market but is projected grow at a higher CAGR (6%) duringthe forecast period from 2018-2030 owingtoits low cost as compared toproducts withpurityabove97%.
Product Definition:
Chlorthalidone is a diuretic agent used to treat hypertension and edema. It inhibits the reabsorption of electrolytes in the renal tubules, resulting in an increase in urine output.
Purity Above 97%:
Purity Above 97%, it's usage.
The global purity above 97% (PA97%) market is estimated to witness significant growth over the forecast period. Increasing demand for high strength APIs with enhanced productivity & efficiency, low environmental impact, and reduced raw material costs are expected to drive the PA97% industry over the next seven years.
Purity Less than or equal to 97%:
Purity less than or equal to 97% is a colorless and water-soluble organic compound. It has a mild odor similar to that of gasoline. Purity less than or equal to 97% can be manufactured by the fractional distillation process, which involves condensing the vaporized feedstock with steam in an attempt to extract every last drop of oil and impurities present in it.
Application Insights:
The research use of chlorthalidone accounted for the largest revenue share in 2017 and is expected to continue its dominance over the forecast period. The drug has a wide range of applications in various fields such as diabetes, cardiovascular diseases, hypertension, osteoporosis and others. It is also used for weight reduction purposes under medical supervision.
The pharmaceutical industry is anticipated to witness lucrative growth during the forecast period on account of increasing product utilization in manufacturing generic drugs which are widely used across several therapeutic segments owing to their low cost and high efficacy. This trend will lead to an increased demand for API chlorthalidone from various end-use industries including cosmetics, personal care & pharmaceuticals which will further propel market growth over the coming years.
Regional Analysis:
North America dominated the global market in 2017 owing to the presence of major companies and well-established research infrastructure. Moreover, increasing R&D activities for new drug development coupled with stringent regulations by FDA are expected to drive regional growth over the forecast period.
Asia Pacific is anticipated to witness lucrative CAGR during the forecast period due to rising healthcare expenditure and improving economic conditions in emerging countries such as China, India, South Korea & Taiwan. Furthermore, growing pharmaceutical industry coupled with government support is expected fuel regional demand during the forecast period. For instance; In March 2015; The Chinese Government announced a USD X billion investment initiative for developing new medicines that were developed using Chlorthalidone API (pure or blended).
Growth Factors:
- Increasing prevalence of hypertension and other heart diseases: The global prevalence of hypertension is expected to increase from 972 million in 2015 to 1.5 billion by 2025. This will create a large pool of patients who will require treatment, thereby driving the demand for Chlorthalidone API.
- Growing awareness about the benefits of early diagnosis and treatment: There is an increasing awareness among people about the importance of early diagnosis and treatment for heart diseases. This is likely to drive the demand for Chlorthalidone API in the coming years.
- Rising incidence of lifestyle-related disorders: The incidence of lifestyle-related disorders such as obesity and diabetes is on the rise globally, which has led to an increase in cases of hypertension and other heart diseases. This will create a large market for Chlorthalidone API in the coming years.
Scope Of The Report
Report Attributes
Report Details
Report Title
Chlorthalidone API Market Research Report
By Type
Purity Above 97%, Purity Less than or equal to 97%
By Application
Research Use, Pharmaceutical Industry
By Companies
IPCA, Triveni Interchem Private Limited (Group Of Triveni Chemicals), Wellona Pharma, Shreeji Pharma, Salavidas Pharmaceutical, KarpsChem, MENADIONA
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
248
Number of Tables & Figures
174
Customization Available
Yes, the report can be customized as per your need.
Global Chlorthalidone API Market Report Segments:
The global Chlorthalidone API market is segmented on the basis of:
Types
Purity Above 97%, Purity Less than or equal to 97%
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Research Use, Pharmaceutical Industry
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- IPCA
- Triveni Interchem Private Limited (Group Of Triveni Chemicals)
- Wellona Pharma
- Shreeji Pharma
- Salavidas Pharmaceutical
- KarpsChem
- MENADIONA
Highlights of The Chlorthalidone API Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Purity Above 97%
- Purity Less than or equal to 97%
- By Application:
- Research Use
- Pharmaceutical Industry
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Chlorthalidone API Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Chlorthalidone API is a prescription medication used to treat high blood pressure. It works by reducing the amount of blood that flows through your veins.
Some of the key players operating in the chlorthalidone api market are IPCA, Triveni Interchem Private Limited (Group Of Triveni Chemicals), Wellona Pharma, Shreeji Pharma, Salavidas Pharmaceutical, KarpsChem, MENADIONA.
The chlorthalidone api market is expected to register a CAGR of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Chlorthalidone API Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Chlorthalidone API Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Chlorthalidone API Market - Supply Chain
4.5. Global Chlorthalidone API Market Forecast
4.5.1. Chlorthalidone API Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Chlorthalidone API Market Size (000 Units) and Y-o-Y Growth
4.5.3. Chlorthalidone API Market Absolute $ Opportunity
5. Global Chlorthalidone API Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Chlorthalidone API Market Size and Volume Forecast by Type
5.3.1. Purity Above 97%
5.3.2. Purity Less than or equal to 97%
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Chlorthalidone API Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Chlorthalidone API Market Size and Volume Forecast by Application
6.3.1. Research Use
6.3.2. Pharmaceutical Industry
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Chlorthalidone API Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Chlorthalidone API Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Chlorthalidone API Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Chlorthalidone API Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Chlorthalidone API Demand Share Forecast, 2019-2026
9. North America Chlorthalidone API Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Chlorthalidone API Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Chlorthalidone API Market Size and Volume Forecast by Application
9.4.1. Research Use
9.4.2. Pharmaceutical Industry
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Chlorthalidone API Market Size and Volume Forecast by Type
9.7.1. Purity Above 97%
9.7.2. Purity Less than or equal to 97%
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Chlorthalidone API Demand Share Forecast, 2019-2026
10. Latin America Chlorthalidone API Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Chlorthalidone API Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Chlorthalidone API Market Size and Volume Forecast by Application
10.4.1. Research Use
10.4.2. Pharmaceutical Industry
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Chlorthalidone API Market Size and Volume Forecast by Type
10.7.1. Purity Above 97%
10.7.2. Purity Less than or equal to 97%
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Chlorthalidone API Demand Share Forecast, 2019-2026
11. Europe Chlorthalidone API Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Chlorthalidone API Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Chlorthalidone API Market Size and Volume Forecast by Application
11.4.1. Research Use
11.4.2. Pharmaceutical Industry
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Chlorthalidone API Market Size and Volume Forecast by Type
11.7.1. Purity Above 97%
11.7.2. Purity Less than or equal to 97%
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Chlorthalidone API Demand Share, 2019-2026
12. Asia Pacific Chlorthalidone API Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Chlorthalidone API Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Chlorthalidone API Market Size and Volume Forecast by Application
12.4.1. Research Use
12.4.2. Pharmaceutical Industry
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Chlorthalidone API Market Size and Volume Forecast by Type
12.7.1. Purity Above 97%
12.7.2. Purity Less than or equal to 97%
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Chlorthalidone API Demand Share, 2019-2026
13. Middle East & Africa Chlorthalidone API Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Chlorthalidone API Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Chlorthalidone API Market Size and Volume Forecast by Application
13.4.1. Research Use
13.4.2. Pharmaceutical Industry
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Chlorthalidone API Market Size and Volume Forecast by Type
13.7.1. Purity Above 97%
13.7.2. Purity Less than or equal to 97%
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Chlorthalidone API Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Chlorthalidone API Market: Market Share Analysis
14.2. Chlorthalidone API Distributors and Customers
14.3. Chlorthalidone API Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. IPCA
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Triveni Interchem Private Limited (Group Of Triveni Chemicals)
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Wellona Pharma
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Shreeji Pharma
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Salavidas Pharmaceutical
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. KarpsChem
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. MENADIONA
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. COMPANY8
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. COMPANY9
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
